DBA Sempra 5.750% Junior Subordinated Notes due 2079 (SREA) traded up 1.59% to a current price of $21.15 as of the 2026-04-03 market close. This analysis reviews recent trading dynamics for the fixed income instrument, key technical support and resistance levels, prevailing market context for utility sector debt, and potential near-term price scenarios based on current technical and macro signals. No recent earnings data is available for this instrument, as it is a subordinated note rather than
SREA Stock Analysis: DBA Sempra 5.750% 2079 Junior Subordinated Notes Gain 1.59 Pct to 21.15
SREA - Stock Analysis
3771 Comments
550 Likes
1
Ker
Trusted Reader
2 hours ago
Anyone else want to talk about this?
👍 227
Reply
2
Yovonda
Trusted Reader
5 hours ago
Real-time US stock market capitalization analysis and size classification for appropriate risk assessment. We help you understand how company size impacts volatility and expected returns in different market conditions.
👍 99
Reply
3
Yeraldy
Experienced Member
1 day ago
Free US stock earnings analysis and guidance reviews to understand company fundamentals and future prospects for better investment decisions. Our earnings season coverage includes detailed analysis of financial results and what they mean for your investment thesis. We provide earnings previews, whisper numbers, and actual versus estimate analysis for comprehensive coverage. Understand earnings better with our comprehensive analysis and expert insights designed for informed decision making.
👍 172
Reply
4
Condoleezza
Senior Contributor
1 day ago
Real-time US stock market breadth indicators and technical analysis to gauge overall market health and direction for better timing decisions. We provide comprehensive market timing tools that help you make better decisions about when to be aggressive or defensive. Our platform offers advance-decline analysis, new high-low indicators, and volume analysis across all major indices. Make better timing decisions with our breadth indicators, technical analysis, and market health monitoring tools.
👍 224
Reply
5
Zayed
Daily Reader
2 days ago
Free access to US stock insights, technical analysis, and curated picks focused on helping investors achieve consistent returns with controlled risk exposure. We believe in transparency and provide complete analysis behind every recommendation we make. Access real-time data, expert commentary, and actionable strategies designed for investors at every level. Join thousands who trust our platform for smart investment decisions, steady portfolio growth, and professional-grade research at no cost.
👍 220
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.